FDA regulation

The rise of artificial‑intelligence‑driven therapy chatbots has sparked intense debate among mental‑health professionals, technology developers, and regulators. Psychologists laud the platforms for expanding access to support, while technologists argue that the next wave of digital care will be powered by conversational agents that can deliver evidence‑based interventions at scale. At...